BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36278951)

  • 21. Indexed left ventricular mass to QRS voltage ratio is associated with heart failure hospitalizations in patients with cardiac amyloidosis.
    Slivnick JA; Wallner AL; Vallakati A; Truong VT; Mazur W; Elamin MB; Tong MS; Raman SV; Zareba KM
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1043-1051. PubMed ID: 33068247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transthyretin Cardiac Amyloidosis in Black Americans.
    Shah KB; Mankad AK; Castano A; Akinboboye OO; Duncan PB; Fergus IV; Maurer MS
    Circ Heart Fail; 2016 Jun; 9(6):e002558. PubMed ID: 27188913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.
    Kittleson MM; Maurer MS; Ambardekar AV; Bullock-Palmer RP; Chang PP; Eisen HJ; Nair AP; Nativi-Nicolau J; Ruberg FL;
    Circulation; 2020 Jul; 142(1):e7-e22. PubMed ID: 32476490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions.
    Khedraki R
    Curr Opin Cardiol; 2022 May; 37(3):272-284. PubMed ID: 35612939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction.
    Griffin JM; Maurer MS
    Trends Cardiovasc Med; 2021 Jan; 31(1):59-66. PubMed ID: 31889610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid transthyretin cardiac amyloidosis: diagnosis and management.
    Di Giovanni B; Gustafson D; Delgado DH
    Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):673-681. PubMed ID: 31478389
    [No Abstract]   [Full Text] [Related]  

  • 27. Amyloidosis in Heart Failure.
    Ihne S; Morbach C; Obici L; Palladini G; Störk S
    Curr Heart Fail Rep; 2019 Dec; 16(6):285-303. PubMed ID: 31782077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Cardiac Amyloidosis: Do's and Don'ts.
    Alexander KM; Witteles RM
    Can J Cardiol; 2020 Mar; 36(3):444-446. PubMed ID: 32033795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.
    Buxbaum JN; Ruberg FL
    Genet Med; 2017 Jul; 19(7):733-742. PubMed ID: 28102864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
    Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
    Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid cardiomyopathy.
    Karafiatova L; Pika T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):117-127. PubMed ID: 28145535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.
    Hassan W; Al-Sergani H; Mourad W; Tabbaa R
    Tex Heart Inst J; 2005; 32(2):178-84. PubMed ID: 16107109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiac amyloidosis : simplifying the diagnosis of a complex disease].
    Dayer N; Monney P; Hugelshofer S
    Rev Med Suisse; 2024 May; 20(875):1010-1017. PubMed ID: 38783670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and Outcomes of p.Val142Ile
    Chandrashekar P; Alhuneafat L; Mannello M; Al-Rashdan L; Kim MM; Dungu J; Alexander K; Masri A
    Circ Genom Precis Med; 2021 Oct; 14(5):e003356. PubMed ID: 34461737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac Care of Patients with Cardiac Amyloidosis.
    Itzhaki Ben Zadok O; Kornowski R
    Acta Haematol; 2020; 143(4):343-351. PubMed ID: 32408301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.
    Budweg J; Al-Ani M; Assaf Y; Parker A; Aranda J
    BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37080632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac amyloidosis-A review of current literature for the practicing physician.
    Ash S; Shorer E; Ramgobin D; Vo M; Gibbons J; Golamari R; Jain R; Jain R
    Clin Cardiol; 2021 Mar; 44(3):322-331. PubMed ID: 33595871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transthyretin Cardiac Amyloidosis.
    Mankad AK; Shah KB
    Curr Cardiol Rep; 2017 Aug; 19(10):97. PubMed ID: 28840452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage.
    Izumiya Y; Hayashi H; Ishikawa H; Shibata A; Yoshiyama M
    Intern Med; 2021 Jan; 60(1):1-7. PubMed ID: 32713926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.